Evidence map›Paper›PMID 40535328›Full record

ArticleNEJM AI2025

Longitudinal Risk Prediction for Pediatric Glioma with Temporal Deep Learning.

Divyanshu Tak, Biniam A Garomsa, Anna Zapaishchykova, Zezhong Ye, Sridhar Vajapeyam, Maryam Mahootiha, Juan Carlos Climent Pardo, Ceilidh Smith, Ariana M Familiar, Tafadzwa L Chaunzwa and 9 more

Abstract read
In one paragraph

Article in NEJM AI, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Divyanshu TakArtificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston.ORCID 0009-0003-4183-209X
Biniam A GaromsaArtificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston.ORCID 0009-0009-8908-8769
Anna ZapaishchykovaArtificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston.ORCID 0000-0001-6860-9160
Zezhong YeArtificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston.ORCID 0000-0003-0369-7432
Sridhar VajapeyamBoston Children's Hospital, Harvard Medical School, Boston.ORCID 0000-0002-1782-1919
Maryam MahootihaDepartment of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston.ORCID 0000-0003-3964-8114
Juan Carlos Climent PardoDepartment of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston.ORCID 0009-0007-9110-2043
Ceilidh SmithDepartment of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston.ORCID 0009-0001-5923-7622
Ariana M FamiliarChildren's Hospital of Philadelphia, Philadelphia.ORCID 0000-0002-9315-8653
Tafadzwa L ChaunzwaArtificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston.ORCID 0000-0001-7216-159X
Kevin X LiuDepartment of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston.ORCID 0000-0003-2071-5137
Sanjay P PrabhuBoston Children's Hospital, Harvard Medical School, Boston.ORCID 0000-0003-0871-115X
Pratiti BandopadhayayDana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston.ORCID 0000-0002-4175-4760
Ali NabavizadehChildren's Hospital of Philadelphia, Philadelphia.ORCID 0000-0002-0380-4552
Sabine MuellerUniversity of Pennsylvania, Philadelphia.ORCID 0000-0002-3452-5150
Hugo J W L AertsArtificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston.ORCID 0000-0002-2122-2003
Daphne Haas-KoganDepartment of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston.ORCID 0000-0002-2378-4800
Tina Y PoussaintBoston Children's Hospital, Harvard Medical School, Boston.ORCID 0000-0002-0814-0791
Benjamin H KannArtificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston.ORCID 0000-0002-4313-2754

Funding

Targeting the Vasular SystemP50CA165962 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI KEITH LLOYD LIGON · 2013 to 2026
$33.5M
Shared Resource Core 2: Clinical Artificial Intelligence CoreU54CA274516 · NCI · DANA-FARBER CANCER INST · PI Benjamin Harris Kann · 2023 to 2026
$8.1M
Development of an artificial intelligence-driven, imaging-based platform for pretreatment identification of extranodal extension in head and neck cancerK08DE030216 · NIDCR · BRIGHAM AND WOMEN'S HOSPITAL · PI KANN, BENJAMIN HARRIS · 2021 to 2025
$841k
NCI NIH HHS P50 CA165962NCI NIH HHS U54 CA274516NIDCR NIH HHS K08 DE030216
6 · The paper itself

Abstract

backgroundPediatric glioma recurrence can cause morbidity and mortality; however, recurrence patterns and severity are heterogeneous and challenging to predict with established clinical and genomic markers. As a result, almost all children undergo frequent, long-term, magnetic resonance imaging (MRI) brain surveillance regardless of individual recurrence risk. Longitudinal deep-learning analysis of serial MRI scans may be an effective approach for improving individualized recurrence prediction in gliomas and other cancers, but, thus far, progress has been limited by data availability and current machine-learning approaches.

methodsWe developed a self-supervised temporal deep-learning approach tailored for longitudinal medical imaging analysis, wherein a multistep model encodes patients' serial MRI scans and is trained to classify the correct chronological order as a pretext task. The pretrained model is then fine-tuned to predict the primary end point of interest - in this case, 1-year recurrence prediction for pediatric gliomas from the point of last scan - by leveraging a patient's historical postoperative surveillance scans. We apply the model across 3994 scans from 715 patients followed at three separate institutions in the setting of pediatric low- and high-grade gliomas.

resultsLongitudinal imaging analysis with temporal learning improved recurrence prediction performance (F1 score) by up to 58.5% (range, 6.6 to 58.5%) compared with traditional approaches across datasets, with performance improvements in both low- and high-grade gliomas and area under the receiver operating characteristic curve of (range, 75 to 89%) across all datasets. Recurrence prediction performance increased incrementally with the number of historical scans available per patient, reaching plateaus between three and six scans, depending on the dataset.

conclusionsTemporal deep learning enables high-performing longitudinal medical imaging analysis and point-of-care decision support for pediatric brain tumors. Temporal learning may be broadly adaptable to track and predict risk in patients with other cancers and chronic diseases undergoing surveillance imaging. (Funded in part by the National Institutes of Health/National Cancer Institute (U54 CA274516 and P50 CA165962), and Botha-Chan Low Grade Glioma Consortium.).

Identifiers

PMID40535328
PMCPMC12176428

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.